FACBC for Recurrent Prostate Cancer

NCT01808222 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Prostate Cancer

Interventions

DRUG: FACBC

Sponsor

David M. Schuster, MD